Aurobindo, Hetero, and Vivimed Class Action Settlements in Missouri
Aurobindo, Hetero, and Vivimed class action settlements that covered Missouri residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Missouri residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Missouri Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Missouri
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Missouri residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed can pursue claims under both federal regulations and Missouri's Merchandising Practices Act, which provides strong consumer protections against deceptive business practices. These pharmaceutical companies distribute their generic medications throughout Missouri via major pharmacy chains and hospital systems, making contamination issues particularly widespread across the state. The $15.2 million valsartan, losartan, and irbesartan class action settlement addresses NDMA contamination found in these manufacturers' products. Missouri follows federal court procedures for multi-district litigation, meaning most pharmaceutical class actions are consolidated in federal court rather than state court. The Missouri Attorney General's Consumer Protection Division actively monitors pharmaceutical settlements and maintains resources for residents seeking compensation. Missouri's statute of limitations for product liability claims is five years from the date of injury discovery, though class action settlements often have their own specific filing deadlines that override state limitations periods.
Aurobindo, Hetero, and Vivimed Settlements in Missouri: FAQs
How does Missouri's consumer protection law apply to Aurobindo, Hetero, and Vivimed contaminated medication cases?
Missouri's Merchandising Practices Act allows residents to seek damages for deceptive practices by pharmaceutical companies, including failure to disclose contamination risks. This state law works alongside federal FDA regulations to provide additional legal remedies for Missouri consumers affected by NDMA-contaminated blood pressure medications from these manufacturers.
What portion of the $15.2 million settlement might Missouri residents receive from Aurobindo, Hetero, and Vivimed?
Individual settlement amounts depend on factors like duration of medication use, medical complications, and documentation of harm rather than geographic location. Missouri residents who took contaminated valsartan, losartan, or irbesartan from these manufacturers during specified time periods may be eligible for compensation ranging from minimal administrative payments to thousands of dollars for proven injuries.
Where should Missouri residents file claims against these three pharmaceutical companies?
Most Aurobindo, Hetero, and Vivimed contamination cases are handled through federal multidistrict litigation rather than Missouri state courts. Missouri residents should work with attorneys experienced in pharmaceutical MDL cases, as these complex proceedings require specific expertise in federal court procedures and mass tort coordination across multiple states.
Tips for Missouri Residents Filing Aurobindo, Hetero, and Vivimed Claims
Missouri residents filing Aurobindo, Hetero, and Vivimed claims should gather all prescription records showing medication lot numbers and dates of use. Document any medical issues that developed while taking these blood pressure medications, including diagnostic tests and treatment records. Contact attorneys experienced with pharmaceutical MDL cases rather than general personal injury lawyers, as these settlements involve complex federal court procedures. Submit claims before deadlines specified in settlement agreements, which typically override Missouri's standard five-year statute of limitations. Keep copies of all pharmacy receipts and insurance records showing purchases of valsartan, losartan, or irbesartan from these manufacturers during contamination periods.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
